Company Analysis

Harvard Bioscience, Inc. (HBIO)

Nasdaq: HBIO · Laboratory Analytical Instruments · Holliston, MA · filing with the SEC since 2000
Grade2.8
◀ Past 1.6● Present 3.1▶ Future 3.7

Who runs Harvard Bioscience, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Duke John D
Chief Executive Officer. First filing Jun 2025, latest Mar 23, 2026, 1 filing in all.
Officers reporting now
4
of 8 people with a filing in the last fifteen months
Directors reporting now
4
24 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Gagnon Robert E.Chief Financial OfficerNov 2013Jun 11, 2026none
Frost Mark TChief Financial OfficerMay 2025Apr 1, 2026none
Duke John DChief Executive OfficerJun 2025Mar 23, 2026none
Green James WChief Executive OfficerApr 2015Aug 19, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Eade Katherine A.directorNov 2017Jun 12, 2026none
Benson Seth BenjamindirectorJul 2025Jun 11, 2026none
Denelsky Stephen JdirectorSep 2025Jun 11, 2026none
Snider WilliamdirectorDec 2025Jun 11, 2026none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton HBIO · research, not advice